Minister of State for AYUSH, Shripad Yesso Naik said that the enforcement of regulatory provisions for ayurveda, siddha, unani, and homoeopathy medicines is presently vested with state governments but there is no separate regulatory authority at the central level.
"Therefore, considering the distinct nature of ayurvedic, siddha, unani, and homoeopathy medicines and huge size of its industry, the Government, on recommendation of Ayurvedic, Siddha and Unani Drugs Consultative Committee, has moved a proposal to set up a separate central authority," the minister said in a reply in Lok Sabha.
The objective is to oversee the implementation of relevant provisions of the Drugs and Cosmetics Act, 1940 and develop improved coordination between central and state regulatory authorities for effective quality control of AYUSH drugs.
Final decision in this regard has not yet been taken, the minister added.
Naik also gave details of action initiated against the offenders regarding spurious, sub-standard, adulterated and expired AYUSH medicines reported and investigated.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
